Nanoparticle Delivery of Cancer Drugs
Top Cited Papers
- 18 February 2012
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 63 (1), 185-198
- https://doi.org/10.1146/annurev-med-040210-162544
Abstract
Nanomedicine, the application of nanotechnology to medicine, enabled the development of nanoparticle therapeutic carriers. These drug carriers are passively targeted to tumors through the enhanced permeability and retention effect, so they are ideally suited for the delivery of chemotherapeutics in cancer treatment. Indeed, advances in nanomedicine have rapidly translated into clinical practice. To date, there are five clinically approved nanoparticle chemotherapeutics for cancer and many more under clinical investigation. In this review, we discuss the various nanoparticle drug delivery platforms and the important concepts involved in nanoparticle drug delivery. We also review the clinical data on the approved nanoparticle therapeutics as well as the nanotherapeutics under clinical investigation.Keywords
This publication has 62 references indexed in Scilit:
- Protein nanoparticles as drug carriers in clinical medicineAdvanced Drug Delivery Reviews, 2008
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProceedings of the National Academy of Sciences of the United States of America, 2008
- Nanoparticles in Medicine: Therapeutic Applications and DevelopmentsClinical Pharmacology & Therapeutics, 2007
- Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.Clinical Cancer Research, 2006
- Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast CancerJournal of Clinical Oncology, 2005
- Target-Specific Cellular Uptake of PLGA Nanoparticles Coated with Poly(l-lysine)−Poly(ethylene glycol)−Folate ConjugateLangmuir, 2005
- Liposomal encapsulated anti-cancer drugsAnti-Cancer Drugs, 2005
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Nanoparticle-Aptamer BioconjugatesCancer Research, 2004
- Liposomes: the Babraham connectionChemistry and Physics of Lipids, 1993